PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,212,000 | +229.3% | 162,500 | +162.7% | 0.03% | +183.3% |
| Q4 2017 | $368,000 | -82.6% | 61,850 | -87.6% | 0.01% | -91.8% |
| Q2 2016 | $2,110,000 | +24.3% | 500,000 | +47.9% | 0.15% | +108.6% |
| Q3 2013 | $1,698,000 | +24.1% | 338,136 | +10.3% | 0.07% | -49.3% |
| Q2 2013 | $1,368,000 | – | 306,650 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|